Relistor Tablet
Product Images NDC 65649-150

Product Visual Gallery

This gallery contains 62 technical images submitted to the FDA as part of the official labeling for Relistor (NDC 65649-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Salix Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

This appears to be a table with data on various treatments and their effectiveness for patients. Not enough context is given to determine what condition or illness is being treated.*

FDA Label Image

Figurea2.jpg (Figurea2)

This is a diagram of different parts of a vial and syringe, including a cap, rubber stopper, plunger, needle, and barrel needle cap. The figure A shows a retractable needle plunger.*

FDA Label Image

Figurea3.jpg (Figurea3)

This appears to be a diagram or image of parts related to vials and syringes. The text indicates various components, including a rubber stopper, top of the plunger, barrel, needle cap, and retractable needle. The image shows a labeled diagram with these parts identified. No additional information or context is available.*

FDA Label Image

Figurebandc1.jpg (Figurebandc1)

FDA Label Image

Figurebandc2.jpg (Figurebandc2)

FDA Label Image

Figurebandc3.jpg (Figurebandc3)

FDA Label Image

Figured1.jpg (Figured1)

FDA Label Image

Figured2.jpg (Figured2)

FDA Label Image

Figured3.jpg (Figured3)

FDA Label Image

Figuree1.jpg (Figuree1)

FDA Label Image

Figuree2.jpg (Figuree2)

FDA Label Image

Figuree3.jpg (Figuree3)

FDA Label Image

Figuref1.jpg (Figuref1)

FDA Label Image

Figuref2.jpg (Figuref2)

FDA Label Image

Figuref3.jpg (Figuref3)

FDA Label Image

Figureg1.jpg (Figureg1)

FDA Label Image

Figureg2.jpg (Figureg2)

FDA Label Image

Figureg3.jpg (Figureg3)

FDA Label Image

Figureh1.jpg (Figureh1)

FDA Label Image

Figureh2.jpg (Figureh2)

FDA Label Image

Figureh3.jpg (Figureh3)

FDA Label Image

Figurei1.jpg (Figurei1)

FDA Label Image

Figurei2.jpg (Figurei2)

FDA Label Image

Figurei3.jpg (Figurei3)

FDA Label Image

Figurej2.jpg (Figurej2)

The text appears to be a technical instruction for administering medication through a syringe. It describes how to align the plunger with the 0.4 mL dose mark on the syringe barrel. The text is accompanied by a figure demonstrating the correct alignment.*

FDA Label Image

Figurej3.jpg (Figurej3)

FDA Label Image

Figurek1.jpg (Figurek1)

FDA Label Image

Figurek2.jpg (Figurek2)

FDA Label Image

Figurek3.jpg (Figurek3)

FDA Label Image

Figurel2.jpg (Figurel2)

FDA Label Image

Figurel3.jpg (Figurel3)

FDA Label Image

Figurem2.jpg (Figurem2)

FDA Label Image

Figurem3.jpg (Figurem3)

FDA Label Image

Figuren2.jpg (Figuren2)

FDA Label Image

Figuren3.jpg (Figuren3)

FDA Label Image

Figureo2.jpg (Figureo2)

FDA Label Image

Figureo3.jpg (Figureo3)

FDA Label Image

Figurep2.jpg (Figurep2)

FDA Label Image

Figurep3.jpg (Figurep3)

FDA Label Image

Figureq2.jpg (Figureq2)

Not available.*

FDA Label Image

Figureq3.jpg (Figureq3)

FDA Label Image

Figurer2.jpg (Figurer2)

FDA Label Image

Figurer3.jpg (Figurer3)

FDA Label Image

Figures2.jpg (Figures2)

FDA Label Image

Figures3.jpg (Figures3)

FDA Label Image

Figuret3.jpg (Figuret3)

FDA Label Image

Figuretandu2.jpg (Figuretandu2)

FDA Label Image

Figurev2.jpg (Figurev2)

FDA Label Image

Relistorcarton1 (Image 01)

FDA Label Image

Chemstructure (Image 02)

FDA Label Image

Figurej2 (Image 03)

FDA Label Image

Image 04

FDA Label Image

Image 05

FDA Label Image

Image 06

FDA Label Image

Image 07

This is a description of a medication called RELISTOR containing pre-filled syringes of methylnaltrexone bromide for subcutaneous injection. The package includes seven syringes and four inserts with prescribing information, instructions, and a medication guide. Each syringe contains 12 mg of methylnaltrexone bromide, sodium chloride, edstate calcium disodium, and glycine hydrochloride. Dosage and administration may vary by patient weight. The medication should be kept at controlled room temperature and should not be frozen. The medication is manufactured by Progenics Pharmaceutical and is a trademark of Salix Pharmaceuticals. A pharmacist should dispense the medication guide to each patient.*

FDA Label Image

Image 08

FDA Label Image

Image 09

FDA Label Image

Image 10

FDA Label Image

Image 11

FDA Label Image

Image 12

FDA Label Image

Image 13

The text describes a package containing seven pre-filled syringes of RELISTOR® (methylnaltrexone bromide) Subcutaneous Injection for administration in patients. Each syringe contains 8 mg of methylnaltrexone bromide in 0.4 mL of water, and the dose may vary by patient weight. The package insert contains dosage and administration instructions, prescribing information, and a medication guide. The medication should be kept out of the reach of children and stored between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The medication should not be frozen, and it is distributed by Salix.*

FDA Label Image

Syringe1.jpg (Syringe1)

The text describes a pre-filled syringe with parts including a syringe barrel, a needle cap, a needle guard, a plunger, and a needle. The image labeled "Figure A" may illustrate these parts.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.